Literature DB >> 3293849

Plasmodium falciparum: inhibition/reversal of cytoadherence of Thai isolates to melanoma cells by local immune sera.

B Singh1, M Ho, S Looareesuwan, E Mathai, D A Warrell, M Hommel.   

Abstract

The effect of sera on the cytoadherence in vitro of Plasmodium falciparum-infected erythrocytes to melanoma cells was examined. Sera from 19 healthy individuals living in endemic malarious areas in Thailand and 24 patients with P. falciparum malaria were tested against four local P. falciparum isolates. Out of 57 sera examined, 12 (21%) showed significant inhibition (greater than 50%) of cytoadherence for at least one isolate. Anti-malarial IgG antibody titres were determined for all 57 sera and although 11 of the 12 inhibitory sera had relatively high titres, 36 out of 47 sera with similarly high titres showed no significant inhibitory activity. Convalescent sera were no more effective than corresponding acute sera in inhibiting the cytoadherence of erythrocytes infected with any of the four heterologous isolates examined. Sera which significantly inhibited cytoadherence were also capable of reversing cytoadherence, and pooled plasma, from healthy individuals living in malarious areas, was effective in significantly reversing the in vitro cytoadherence of all the five parasite isolates examined. The results confirm the antibody mediated strain-specific nature of the inhibition of cytoadherence and stress the difficulty in selecting immune sera potentially useful for the immunotherapy of cerebral malaria patients in Thailand.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293849      PMCID: PMC1541488     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

Review 1.  Pathophysiology of severe falciparum malaria in man.

Authors:  D A Warrell
Journal:  Parasitology       Date:  1987       Impact factor: 3.234

Review 2.  Recent advances in malaria with special reference to Southeast Asia.

Authors:  T Harinasuta; K E Dixon; D A Warrell; E B Doberstyn
Journal:  Southeast Asian J Trop Med Public Health       Date:  1982-03       Impact factor: 0.267

3.  Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells.

Authors:  I J Udeinya; J A Schmidt; M Aikawa; L H Miller; I Green
Journal:  Science       Date:  1981-07-31       Impact factor: 47.728

4.  Immunofluorescence method suitable for large-scale application to malaria.

Authors:  A Voller; P O'Neill
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  Plasmodium falciparum malaria. An amelanotic melanoma cell line bears receptors for the knob ligand on infected erythrocytes.

Authors:  J A Schmidt; I J Udeinya; J H Leech; R J Hay; M Aikawa; J Barnwell; I Green; L H Miller
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

6.  Protein synthesis in vitro by cryopreserved Plasmodium falciparum.

Authors:  C Diggs; K Joseph; B Flemmings; R Snodgrass; F Hines
Journal:  Am J Trop Med Hyg       Date:  1975-09       Impact factor: 2.345

7.  Amino-sugars inhibit the in vitro cytoadherence of Plasmodium falciparum-infected erythrocytes to melanoma cells.

Authors:  B Singh; M Monsigny; M Hommel
Journal:  Mol Biochem Parasitol       Date:  1987-02       Impact factor: 1.759

8.  The pathophysiology of severe falciparum malaria.

Authors:  R E Phillips; D A Warrell
Journal:  Parasitol Today       Date:  1986-10

9.  Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes.

Authors:  P H David; M Hommel; L H Miller; I J Udeinya; L D Oligino
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells.

Authors:  I J Udeinya; L H Miller; I A McGregor; J B Jensen
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

View more
  7 in total

Review 1.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children.

Authors:  D Dodoo; T Staalsoe; H Giha; J A Kurtzhals; B D Akanmori; K Koram; S Dunyo; F K Nkrumah; L Hviid; T G Theander
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines.

Authors:  P Ringwald; F Peyron; J P Lepers; P Rabarison; C Rakotomalala; M Razanamparany; M Rabodonirina; J Roux; J Le Bras
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  Intravenous immunoglobulin in the treatment of paediatric cerebral malaria.

Authors:  T E Taylor; M E Molyneux; J J Wirima; A Borgstein; J D Goldring; M Hommel
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

5.  Clinical correlates of in vitro Plasmodium falciparum cytoadherence.

Authors:  M Ho; B Singh; S Looareesuwan; T M Davis; D Bunnag; N J White
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children.

Authors:  C L Mackintosh; T Mwangi; S M Kinyanjui; M Mosobo; R Pinches; T N Williams; C I Newbold; K Marsh
Journal:  Int J Parasitol       Date:  2008-04-29       Impact factor: 3.981

7.  In vitro inhibition and reversal of Plasmodium falciparum cytoadherence to endothelium by monoclonal antibodies to ICAM-1 and CD36.

Authors:  Khairul M F Mustaffa; Janet Storm; Megan Whittaker; Tadge Szestak; Alister G Craig
Journal:  Malar J       Date:  2017-07-05       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.